System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Hien Q Huynh is an expert in Gastroenterology at Stollery Children's Hospital (Canada). As of October 2026, ScienceLeadR ranks Hien Q Huynh in the top 1% of experts worldwide for Inflammatory Bowel Diseases and Gastroenteritis. Hien Q Huynh has authored 277 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 3 of them ongoing. SLR score: 879 (community average: 125). How the SLR is computed.

LeadR Profile

Hien Q Huynh Stollery Children's Hospital Canada
879 ScienceLeadR Reputation 879

Unlock

Register Login
Network Map

Gastroenterology

Subspecialties: Pediatrics - Nutrition - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2003 - 2026
Source: PubMed

University of Alberta Faculty of Medicine & Dentistry

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 277

Citations

Citations: 5 028 1st author: 5 Last author: 51 Unique author: 1

Main journals

Gastroenterology 62
J Can Assoc Gastroen 42
J Crohns Colitis 31
J Pediatr Gastroenterol Nutr 27
Inflamm Bowel Dis 9

Best Journals

Gastroenterology 5

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
TASTY AND HEALTHY DIET REDUCES FECAL CALPROTECTIN IN HIGH-RISK FIRST-DEGREE RELATIVES OF PATIENTS WITH CROHN'S DISEASE: PIONIR RANDOMIZED CROSSOVER TRIAL.
PMID 42933673 — gastroenterology, leukocyte l1 antigen complex, crohn disease, capsule endoscopy, diet, diet, healthy, gastrointestinal microbiome		Gastroenterology20260
From Archetypes to Access: A Two-Axis Governance Framework and Decision-Support Tool for Rare Specimen Biobanking.
PMID 42765370 — research		Biopreserv Biobank20260
Ultrasound criteria for transmural healing and response in Crohn's disease: a systematic review of definitions and thresholds.
PMID 42222916 — crohn disease, inflammatory bowel diseases, colitis, ulcerative		Inflamm Bowel Dis20260
β-Glucan and Inulin Estimated Intake Are Associated With Reduced Risk of Crohn's Disease, Improved Gut Barrier and Systemic Inflammation Markers, and Multi-Omic Signatures in a High-Risk Cohort.
PMID 42214560 — glucans, gastroenterology, crohn disease, multiple chronic conditions, inulin, dietary fiber, gastrointestinal microbiome		Gastroenterology20260
IL23R genetic variants associate with Crohn's disease risk and microbiome changes in healthy first-degree relatives.
PMID 42208782 — interleukin-23, genes, crohn disease, polymorphism, single nucleotide		Clin Gastroenterol Hepatol20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

N/A 5
Phase 3 2
Phase 4 1

By status:

Completed 3
Recruiting 3
Active not recruiting 1
Unknown 1

By type:

Interventional 5
Observational 3

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 1
multicentric5to9 0
multicentricup10 4

Main Topics

Cohort/Consortium Investigators 11

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Clinical Imaging and Endoscopic Outcomes of Children Newly Diagnosed With Crohn s Disease
NCT05781152 — intestines, genes, blood, crohn disease, pharmaceutical preparations, drug monitoring, adolescent, inflammatory bowel diseases, adalimumab, therapeutics, colonoscopy, intestine, large, child, gene expression, infliximab		Phase 4Active not recruiting2023
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn s Disease (CD)
NCT05442567 — colitis, safety, crohn disease, pharmaceutical preparations, drug therapy, therapeutics, colitis, ulcerative, child		Phase 3Recruiting2023
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn s Disease (CD)
NCT04779320 — safety, crohn disease, pharmaceutical preparations, drug therapy, maintenance, signs and symptoms, therapeutics, child		Phase 3Recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS